Also called: Teriparatide plus zoledronic acid sequential treatment, Teriparatide followed by Zoledronic Acid (TOPaZ Trial Protocol), Teriparatide plus Zoledronic Acid
Teriparatide is a man-made medicine that acts like a specific hormone your body makes to build bone. It is used by people with weak bones, a condition known as osteoporosis, to help make their bones stronger and prevent breaks. This medicine is different from other bone pills because it helps the body build new bone tissue instead of just stopping bone loss. It is usually given as a daily shot under the skin.
The main goal of using this medicine is to lower the chance of breaking a bone, which can be very painful and make it hard to move. It works by telling the bone-building cells in your body to work harder. This is very helpful for older adults or those who have already had bone breaks. It can make bones thicker and lower the risk of future fractures by a large amount.
There are some important things to know about safety with this medicine. Unlike some other bone drugs, this one does not seem to cause a rare jaw problem called osteonecrosis. This means patients usually do not need to stop taking it for dental work. However, it is a strong medicine that requires a doctor's prescription. It is not for people who need a simple vitamin fix, but for those at high risk of broken bones.
Benefits
The benefits people report — backed by research.
You just read the research on Teriparatide. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
From published sources
Routines as reported in peer-reviewed papers, clinical guidance, or vetted media — each linked to the source it came from.
SubQ
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Evidence
Every claim above traces back to a source you can check — here are 1 of them.
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.
Timeline
Key moments in Teriparatide’s research and regulatory timeline — sourced and dated.
Wondering how Teriparatide pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.